BCS Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
BCS Wealth Management's LLY Position: Q2 2026 in Review
BCS Wealth Management increased its Eli Lilly (LLY) stake by 7.5% in Q2 2026, buying an estimated $140K and bringing the position to 1,962 shares worth $2.35M. The position accounts for 0.42% of the portfolio, ranked #54.
BCS Wealth Management first reported a position in LLY in Q1 2020 and has held it in 23 quarters since. The position peaked at $4.05M in Q1 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- BCS Wealth Management held 1,962 shares of Eli Lilly worth $2.35M as of Q2 2026.
- BCS Wealth Management bought 137 Eli Lilly shares in Q2 2026, an estimated $140K.
- Eli Lilly made up 0.42% of BCS Wealth Management's portfolio in Q2 2026, its #54 holding.
- BCS Wealth Management first reported a position in Eli Lilly in Q1 2020 and has held it in 23 quarters since.
- BCS Wealth Management's Eli Lilly position peaked at $4.05M in Q1 2025.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on BCS Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.